This week we look at the science behind mapping healthcare influencers, the value Medical Science Liaisons offer our industry, the serious focus behind the monitoring of drug side effects, the use of mobile apps by public health departments and medical research collaborations in the development of pharmaceuticals.
Harnessing influence is vital for effective healthcare marketing, but robust, reliable methods of understanding its nature and identifying those who have it are needed. PMLiVE’s Mapping Influencers In Healthcare offers a solid approach to quantitative network analytics that the authors believe will revolutionize healthcare marketing
Medical Science Liaisons (MSLs) are the bridge between a company and key stakeholders that drive marketplace success.Pharmaceutical Industry Relies on Medical Science Liaisons to Generate Value Across a Diverse Set of Customers. The report from Best Practices, LLC provides information on how the roles of MSLs are evolving in the changing pharmaceutical environment and how regulatory concerns are affecting the MSL landscape
Specific regulations exist as to how the pharma industry must handle and report adverse events.The Forbes article,Can Pharma Hide Side Effects of Marketed Drugs In The U.S.?, highlights the detailed and serious work done by pharma company regulatory divisions dedicated to tracking adverse events and reporting these side effects both internally and to the FDA
A growing number of city and state health departments are launching mobile applications to provide residents with information on health and wellness. More Public Health Departments Launching Mobile Applications from iHealthBeat highlights the use of mobile technology as the next big thing in helping people live healthier lives
The future of biomedical innovation depends in part on a new trend for all players in biomedical innovation to work together. In the recent article from ScienceDaily, The Science of Collaboration,outlines a grant from the Robert Wood Johnson Foundation to organize the groundwork for these efforts
That wraps this week’s review of news from and for the pharma insight community. I’ll leave you with an invitation to learn more about the benefits of real time data and offer you a personal demo of InCrowd’s on-demand platform providing you direct and immediate access to Crowds of screened and targeted healthcare professionals.
If you have tips, suggestions or resources you’d like to share leave us a note below and please feel free to suggest topics that you’d like to see covered in future posts.
